当前位置：
X-MOL 学术
›
Ther. Adva. Endocrinol. Metab.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
MAFLD: a multisystem disease
Therapeutic Advances in Endocrinology and Metabolism ( IF 3.8 ) Pub Date : 2023-01-28 , DOI: 10.1177/20420188221145549 Rosaria Maria Pipitone 1 , Carlo Ciccioli 1 , Giuseppe Infantino 1 , Claudia La Mantia 1 , Stefanie Parisi 1 , Adele Tulone 1 , Grazia Pennisi 1 , Stefania Grimaudo 1 , Salvatore Petta 1, 2
Therapeutic Advances in Endocrinology and Metabolism ( IF 3.8 ) Pub Date : 2023-01-28 , DOI: 10.1177/20420188221145549 Rosaria Maria Pipitone 1 , Carlo Ciccioli 1 , Giuseppe Infantino 1 , Claudia La Mantia 1 , Stefanie Parisi 1 , Adele Tulone 1 , Grazia Pennisi 1 , Stefania Grimaudo 1 , Salvatore Petta 1, 2
Affiliation
Nonalcoholic fatty liver disease (NAFLD), affecting about 25% of general population and more than 50% of dysmetabolic patients, is an emerging cause of chronic liver disease and its complications. ...
中文翻译：
MAFLD：一种多系统疾病
非酒精性脂肪性肝病 (NAFLD) 影响了大约 25% 的普通人群和超过 50% 的代谢异常患者，是慢性肝病及其并发症的新病因。...
更新日期：2023-01-31
中文翻译：
MAFLD：一种多系统疾病
非酒精性脂肪性肝病 (NAFLD) 影响了大约 25% 的普通人群和超过 50% 的代谢异常患者，是慢性肝病及其并发症的新病因。...
京公网安备 11010802027423号